BIOPHARM FORWARD ApS: Financial statements 2012
CVR: 32438784
Source: annual report 2012, Danish Business Authority
26/08/2011 – 25/08/2012
BIOPHARM FORWARD ApS (CVR 32438784) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -11,226 and a net result of DKK -47,010. Equity in the 2012 report amounted to DKK -19,367.
- Gross Profit
- DKK -11,226
- Profit/Loss
- DKK -47,010
- Equity
- DKK -19,367
- Total Assets
- DKK 11,928
Official annual report
Keep an eye on BIOPHARM FORWARD ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of January 25, 2012, Bodil Elisabeth Fransiska Ørkild is registered as director of BIOPHARM FORWARD ApS.
As of January 25, 2012, Jonas Hink has stepped down as director of BIOPHARM FORWARD ApS.
About BIOPHARM FORWARD ApS
BIOPHARM FORWARD ApS is a Danish company of the type Anpartsselskab based in Espergærde, founded in 2009. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jonas Hink. The company is owned by Jonas Hink. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK 997,234 and a net result of DKK 243,660 compared with DKK 385,061 the year before. Equity in the 2025 report amounted to DKK 1,741,315.